Department of Urology Grand Rounds: Charles C. Peyton, MD

The University of Florida Department of Urology invites you to attend
Grand Rounds

picture of dr. charles peyton

Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer:the Return of MVAC

Charles C. Peyton, MD
Urologic Oncology Fellow
Moffitt Cancer Center

Thursday, May 31, 2018
7:00 am
Department of Urology Conference Room, M2-203C

Learning Objectives

Review the principles, advantages and disadvantages of neoadjuvant chemotherapy for muscle invasive bladder cancer
Understand the important clinical trials in support of neoadjuvant chemotherapy
Review the key differences and evidence for various neoadjuvant chemotherapy regimens
Highlight emerging data in support of dose-dense or accelerated MVAC prior to radical cystectomy

Target Audience

Urologists, Residents, Nurses, Physician Assistants, and Staff


The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.


The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.

Contact Information

If you have any questions please feel free to contact Stephanie Stenner at


Dr. Peyton has disclosed that he has no relevant financial relationships. Dr. Vincent Bird, Planning Committee, is a consultant for Boston Scientific. No one else in a position to control content has any financial relationship to disclose.

Section Number: 8119


Florida’s Leading Academic Urology Program

Rated as High Performing Urology Program

Rated as High Performing in Prostate Cancer Surgery